ct scanning ffr-ct handouts - bryan health · t h e p l a t f o r m t r i a l ccm-100-051-f 0.77...
TRANSCRIPT
8/31/2016
1
September 2016
Non-Invasive FFRCT
Optimizing Outcomes with Physiology-Guided Coronary Revascularization
Clyde R. Meckel, MDBryan Heart
CCM-100-051-F
62%
38%
Non-obstructive CAD Obstructive CAD
Positive stress tests lead to large numbers of unnecessary invasive angiograms
Patel et al, NEJM 2010.
Nearly 2/3rd of patients
without known CAD who went to elective
diagnostic angiogram were found to have no
obstructive disease
Data from an
analysis of
approximately
400,000 patients at
over 650 US
hospitals
1
CCM-100-051-F
Vavalle et al, JAMA Cardiology 2016.
This was true for patients with both typical and atypical angina.
2
A recent study of over 15,000 patients found thatPatients with a negative stress test were the most likely to have obstructive CADPatients with a positive stress test were the least likely to have obstructive CAD
0%
10%
20%
30%
40%
50%
60%
70%
80%
Non-obstructive/ No CAD
Obstructive CAD
Stress Tests w/ Atypical Angina
0%
10%
20%
30%
40%
50%
60%
70%
80%
NegativeResult
PositiveResult
No Test NegativeResult
PositiveResult
No Test
Stress Tests w/ Typical Angina
Negative stress tests often miss serious CAD
8/31/2016
2
CCM-100-051-F
FFR is a Better Measurement:Accepted Gold Standard for Identifying CAD
3
But not clinically adopted
InvasiveTime consumingExpensive
CCM-100-051-F
ANATOMYIdentify Obstructive CAD
Identifying Anatomically & Functionally Significant CAD
FUNCTIONIdentify ischemia that may
benefit from PCI
4
NON-INVASIVE
• SPECT• Stress Echocardiography
• Exercise Stress Test• CMR
INVASIVE
CCM-100-051-F
The HeartFlow FFRCT AnalysisAdvances Current Standards
5
Coronary Anatomy
Lesion Specific IschemiaFFRCT
8/31/2016
3
HeartFlow Clinical Data
31 August 2016 Confidential Information
6
• Compare accuracy to FFR
• 103 patients
DISCOVER-FLOW (2011)
• Compare accuracy to FFR and coronary angiography
• 254 patients
NXT (2013)
• Compare accuracy to FFR and cCTA
• 252 patients
DeFACTO (2012)
CCM-100-051-FCT
Nørgaard et al, Eur Radiol 2015
Performance of Coronary Diagnostic Tests for Functional Disease
CCM-100-051-F
The HeartFlow Analysis
Model of coronary
arteries
FFRCT values indicate
functional
significance of CAD
Confidential Information
Summary: The Left Anterior Descending System has an FFRCT <_ 0.80.
MAY BE FUNCTIONALLY SIGNIFICANT 1,2,3
CORONARY ARTERIES & SYSTEMS FFRCT
Left Main Artery 0.98
Left Anterior Descending System 0.61
Left Circumflex System 0.93
Right Coronary Artery System 0.87
FFRCT
0.00 1.000.20 0.40 0.60 0.80
8/31/2016
4
CCM-100-051-F
9
HeartFlow FFRCT Process
A standard CT scan is performed and the data is uploaded to HeartFlow.
CCM-100-051-F
10
HeartFlow FFRCT Process
With cloud-based automation and human oversight, HeartFlow creates a personalized, digital 3D model of the arteries.
A standard CT scan is performed and the data is uploaded to HeartFlow.
CCM-100-051-F
11
HeartFlow FFRCT Process
With cloud-based automation and human oversight, HeartFlow creates a personalized, digital 3D model of the arteries.
Powerful computer algorithms solve millions of complex equations to assess the impact that blockages have on blood flow.
A standard CT scan is performed and the data is uploaded to HeartFlow.
8/31/2016
5
CCM-100-051-F
12
HeartFlow FFRCT Process
With cloud-based automation and human oversight, HeartFlow creates a personalized, digital 3D model of the arteries.
Powerful computer algorithms solve millions of complex equations to assess the impact that blockages have on blood flow.
Physicians interrogate and interpret results to aid in determining, vessel-by-vessel, if sufficient blood is reaching the heart.
A standard CT scan is performed and the data is uploaded to HeartFlow.
CCM-100-051-F
70 y.o. woman with chest pain during exertionHigh cholesterol
Case Example: Using FFRCT to Aid in Choosing a Treatment Path
Medical treatment or intervention for this patient?
Stenoses seen on cCTA
LAD
LAD
13
CCM-100-051-F
No functionally significant lesions presentMedical management
Case Example: Using FFRCT to Aid in Choosing a Treatment Path
LAD
LAD
14
8/31/2016
6
CCM-100-051-F
PLATFORM TRIAL
PI: Pam Douglas, Duke
HECON PI: Mark Hlatky,
Stanford
Prospective clinical utility trial
comparing two distinct patient management strategies.
15
HeartFlow FFRCT Clinical Trial Data are Substantial
vs.FFRCT Guided
StrategyUsual Care
• Primary Endpoint:Patients with a planned ICA– Are patients evaluated
using a CTA/FFRCT
guided strategy less likely to undergo ICAs that show no obstructive CAD?
62%
Health
Costs
Experience
T H E P L A T F O R M T R I A L
CCM-100-051-F
Usual Care CTA/FFRCT Guided
27%
Non-obstructive CADObstructive CAD
27%
73% 12%
61%
ICACanceled
83% reduction
Invasive Catheterization (ICA) with No Obstructive Disease
16Douglas, et al. Presented at ACC 2016.
No adverse clinical
events after 12 months in 117 patients with cancelled ICA
Health
Costs
Experience
T H E P L A T F O R M T R I A L
CCM-100-051-FCTA/FFRCT CohortUsual Care Cohort
ICAs Performed RevascularizationsPerformed
MACE RateFunctional Information
Available Prior to Revasc.
No Difference in Revascularization or MACE Rates Patients with a Planned ICA
17
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
39%
PCIPCI
31.6%28.5%CABG
96%
51%
CABG
100%
1.0%1.1%
Douglas, et al. Presented at ACC 2016.
Health
Costs
Experience
8/31/2016
7
T H E P L A T F O R M T R I A L
CCM-100-051-F
0.77
0.79
0.81
0.83
0.85
0.87
0.89
0.91
Baseline 90 Day Follow-Up
EQ-5D: Non-Invasive Test
Usual Care HeartFlow Guided
Quality of Life Improvements to 90 Days
HeartFlow showed significantly greater improvement
in Quality of Life than evaluation with usual non-invasive testing.
Significant improvements from baseline for all groups.
p=0.002
18
0.77
0.79
0.81
0.83
0.85
0.87
0.89
0.91
Baseline 90 Day Follow-Up
EQ-5D: Planned ICA
Usual Care HeartFlow Guided
Health
Costs
Experience
Hlatky, et al. JACC 2015.
T H E P L A T F O R M T R I A L
CCM-100-051-F
Significant Savings to the Healthcare System
Costs Over 1 Year –
Patients with Planned ICA
*p<0.0001
19
$12,145
$9,036
$0
$2,000
$4,000
$6,000
$8,000
$10,000
$12,000
$14,000
26%Savings*
FFRCT
GuidedUsualCare
Cost savings of 26%
to the health system
after accounting for the $1,500 cost of the HeartFlow Analysis.
Douglas, et al. Presented at ACC 2016.
Health
Costs
Experience